The Details of the Antibodies Used in Study
Clone . | Specificity . | Source . | Tissue . |
---|---|---|---|
Polyclonal | CD3 | Dako Ltd, High Wycombe, UK | P |
UCHT1 | CD3 | Dako Ltd | F |
L26 | CD20 | Dako Ltd | P/F |
1F8 | CD21 | Dako Ltd | P/F |
MIB-1 | Ki-67 antigen | Coulter Electronics Ltd, Luton, UK | P |
Ki67 | Ki67 antigen | Dako Ltd | F |
M90 | CD10 | Dako Ltd | F |
EA-5 | CD38 | Serotec Ltd, Oxford, UK | F |
BB1 | CD80 | Serotec Ltd | F |
BU63 | CD86 | Serotec Ltd | F |
APO-1 | CD95 | Pharmingen, San Diego, CA | F |
124 | bcl-2 | Dako Ltd | P |
R10-21-F3 | Ig κ light chain | Dako Ltd | F |
N10/2 | Ig λ light chain | Dako Ltd | F |
Polyclonal | Ig κ light chain | Dako Ltd | P |
Polyclonal | Ig λ light chain | Dako Ltd | P |
IgD26 | Ig δ heavy chain | Dako Ltd | F |
Polyclonal | Ig δ heavy chain | Dako Ltd | P |
Polyclonal | Ig μ heavy chain | Dako Ltd | P/F |
Polyclonal | Ig γ heavy chain | Dako Ltd | P/F |
Polyclonal | Ig α heavy chain | Dako Ltd | P/F |
Clone . | Specificity . | Source . | Tissue . |
---|---|---|---|
Polyclonal | CD3 | Dako Ltd, High Wycombe, UK | P |
UCHT1 | CD3 | Dako Ltd | F |
L26 | CD20 | Dako Ltd | P/F |
1F8 | CD21 | Dako Ltd | P/F |
MIB-1 | Ki-67 antigen | Coulter Electronics Ltd, Luton, UK | P |
Ki67 | Ki67 antigen | Dako Ltd | F |
M90 | CD10 | Dako Ltd | F |
EA-5 | CD38 | Serotec Ltd, Oxford, UK | F |
BB1 | CD80 | Serotec Ltd | F |
BU63 | CD86 | Serotec Ltd | F |
APO-1 | CD95 | Pharmingen, San Diego, CA | F |
124 | bcl-2 | Dako Ltd | P |
R10-21-F3 | Ig κ light chain | Dako Ltd | F |
N10/2 | Ig λ light chain | Dako Ltd | F |
Polyclonal | Ig κ light chain | Dako Ltd | P |
Polyclonal | Ig λ light chain | Dako Ltd | P |
IgD26 | Ig δ heavy chain | Dako Ltd | F |
Polyclonal | Ig δ heavy chain | Dako Ltd | P |
Polyclonal | Ig μ heavy chain | Dako Ltd | P/F |
Polyclonal | Ig γ heavy chain | Dako Ltd | P/F |
Polyclonal | Ig α heavy chain | Dako Ltd | P/F |
Abbreviations: P, paraffin sections; F, frozen sections; Ig, immunoglobulin.